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Nanophotonics has become a key enabling technology in biomedicine with great promises in 
early diagnosis and less invasive therapies. In this context, the unique capability of plasmonic 
noble metal nanoparticles to concentrate light on the nanometer scale has widely contributed 
to biosensing and enhanced spectroscopy. Recently, high-refractive index dielectric 
nanostructures featuring low loss resonances have been proposed as a promising alternative 
to nanoplasmonics, potentially offering better sensing performances along with full 
compatibility with the microelectronics industry. In this letter we report the first 
demonstration of biosensing with silicon nanoresonators integrated in state-of-the-art 
microfluidics. Our lab-on-a-chip platform enables detecting Prostate Specific Antigen (PSA) 
cancer marker in human serum with a sensitivity that meets clinical needs. These 
performances are directly compared with its plasmonic counterpart based on gold nanorods. 
Our work opens new opportunities in the development of future point-of-care devices 
towards a more personalized healthcare. 
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The need for point-of-care devices in health and wellness monitoring is one of the principal 
motivations behind the current development in biosensing. Among the different available 
transduction schemes, optical biosensors hold the advantage of being highly sensitive, 
enabling label free and cost effective real time sensing
1
. Beyond silicon-based integrated 
optics
2–4
 that shows great promises for sensing, surface plasmon resonance (SPR)
5–8
 and fiber 
optics
9,10
 based sensors utilizing propagating evanescent waves have been extensively studied 
and validated on a wide range of analytes. However, coupling incoming light to the surface 
modes usually requires sophisticated optics and such sensors are often limited to large 
bioanalytes, owing to a substantial spatial mismatch of the sensing mode with the tiniest 
molecules. 
These limitations can partially be overcome by using 3D nano-optical resonators. In 
particular, extensive efforts have been put on localized surface plasmon resonance (LSPR) 
sensors
11–13
 which exploit the unique properties of noble metal nanoantennas. The ability to 
excite LSPR with freely propagating incident light considerably simplifies the optical setup 
needed for such label free measurements. Highly confined modes also provide strong overlap 
between the electromagnetic field on the surface and the relevant biological analyte 
dimensions. Finally, the tiny size of each nanosensors enable their assembly in small foot 
print sensing areas compatible with parallel multi-detection platforms
11–13
. However, 
plasmonic nanoparticles suffer from dissipative losses in the metal that lead to broad 
resonances that eventually limit the sensitivity of the sensor read-out. Recently, high 
refractive index dielectric nanoparticles have been proposed as an attractive alternative to 
plasmonic nanoparticles in wide range of applications.
14,15
  
All-dielectric nanophotonics is a fast progressing field which enables manipulation of both 
electric and magnetic components of the incoming light. These unique properties open up 
new opportunities in the field of metamaterials including negative refractive index, cloaking, 
superlensing and many more.
15–20
 In practice, light coupling to dielectric subwavelength 
particles results in the excitation of both magnetic and electric multipole resonances which 
translates into multiple peaks in their extinction spectrum. Similar to metallic nanoparticles, 
the resonance frequencies depend on their geometry, constitutive material and the dielectric 
environment. Their sensitivity to the surrounding dielectric permittivity along with their 
strong mode localization suggests high index dielectric nanoparticles could perform well as 
biosensing transducers.
14,21–23
 Silicon nanoresonators, with resonances in visible-NIR spectral 
range, were first studied theoretically and more recently measured experimentally
24–28
. The 
use of silicon is motivated by its compatibility with the microelectronics industry, high 
material abundance and low cost. While it has recently been suggested that Si nanoresonators 
could benefit to the detection of biological molecules, so far, only bulk refractive index 
sensing measurements have been reported.
21–23
 
In this letter, we demonstrate that Si nanoresonator arrays integrated with state-of-the-art 
microfluidics result in an efficient sensing platform for the detection of protein cancer 
markers in human serum, at clinically relevant concentrations for cancer screening. We first 
study the optimal structural design of Si nanodisks for molecular sensing. Then, we 
demonstrate detection of PSA (prostate specific antigen) in buffer with a limit of detection 
(LOD) that is comparable to gold standard immunoassay techniques. Finally, to validate its 
operation in clinical conditions, the platform is tested in human serum. 
Our platform consists of silicon nanodisk arrays on a quartz substrate integrated with a 
PDMS microfluidic chip including micromechanical valves (Fig. 1a-c). We fabricate the 
silicon nanodisk arrays using standard negative resist e-beam lithography followed by a 
reactive ion etching step on commercial silicon coated quartz samples (see the Supplementary 
Information). The nanodisk arrays have a fixed height h=50 nm. We choose to tune the disk 
radius r and inter-particle distance s to assess the optimum nanosensor parameters. The 
extinction spectra of the nanodisk arrays are measured using a homemade transmission 
microscopy set-up integrated with a VIS-NIR light source  coupled to a spectrometer
29
. Our 
optical detection enables us to interrogate up to 32 regions in parallel throughout the chip for 
real-time resonance tracking of different sensor arrays.  
The PDMS chip is fabricated by multilayer soft lithography leading to 8 sensing channels 
that are all individually and simultaneously addressable (see the Supplementary 
Information).
29
 The sample flow on the experiment channels is controlled by the 
micromechanical valves
30
 that are thin PDMS membranes between the flow layer and the 
control layer of the chip. By pressurizing the control channels, the thin PDMS membrane 
valve is actuated to control the flow of the samples on the experiment layer. These 
micromechanical valves are pressure-driven by electronic valves that are controlled by a 
home-made graphical user interface.  
The detection of the biomolecules is based on a standard sandwich assay scheme where the 
protein of interest is captured between two specific antibodies, one immobilized on the 
silicon surface, acting as capture antibody and another that is flowed in solution as detection 
antibody (Fig. 1d). The capture antibody is immobilized on the silicon sensors by passive 
adsorption similarly to ELISA and other immunoassay techniques.
31
 The samples, which 
contain different concentrations of the target protein of interest, are then introduced into 
individual channels and the protein is captured by the immobilized antibody. Finally, the 
detection antibody is introduced and is bound to the previously captured protein. This 
amplification step provides higher resonance shifts compared to the shifts obtained by the 
target proteins, offering higher concentration resolution for small proteins. It also increases 
the selectivity of the sensing protocol since the protein of interest is recognized by two 
specific antibodies (see the Supplementary Information). The increased effective refractive 
index at the sensor vicinity resulting from the binding steps (Fig. 1d) causes the resonances of 
the nanodisk arrays to redshift enabling accurate monitoring of the adsorption and binding 
kinetics of the molecules (Fig. 1e).  
 
Figure 1: On-a-chip biosensing with silicon on quartz nanodisks. (a) Picture of an assembled 
chip with 8 sensing channels. (b) Close-up picture of the 8 sensing channels showing silicon 
nanodisk arrays with different parameters. (c) SEM micrograph of a small portion of a silicon 
nanodisk array with h=50nm, r=140 nm and s=200 nm. (d) Schematics of the sensing 
protocol. (e) Evolution of the nanodisk resonance during the different steps of the sandwich 
assay. The sample (100 ng/ml PSA) and control (no PSA) experiments are in grey and purple, 
respectively.  
The extinction spectrum of individual h=50 nm Si nanodisks is mainly dominated by an 
electric dipole resonance (See Supplementary Fig. 1).
28,32
 Here, for sensing purposes, we aim 
at exploiting the strong collective resonance arising from far field dipole coupling. The array 
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resonance is optimized by changing the disk radius (r) and separation (s). Fig. 2 shows the 
measured extinction spectra of the different arrays along with the corresponding Finite 
Element Method (FEM) simulations. The resonances are tuned by changing the periodicity at 
fixed radius (Fig. 2a), or conversely, changing the nanodisk radius at constant disk separation 
(Fig. 2c). The corresponding FEM simulations on infinitely large arrays are in good 
agreement with the measured data (Fig 2b and 2d). The amplitude and width of each of these 
resonances vary for different nanodisk arrays. While these properties are important for the 
detectability of spectral shifts, also the refractive index sensitivity is expected to vary with the 
array parameters. 
 
Figure 2: Resonance tuning of Si-nanodisk arrays. Experimental extinction spectra of silicon 
nanodisk arrays in air: (a) Influence of the disk separations at fixed radius r=140 nm and (b) 
Influence of the disk radius at fixed disk separation of s=200 nm. (c, d) Corresponding FEM 
simulations. Inset in (a) shows the geometry of the disks and the incident light polarization. 
In order to identify the structural parameters (r and s) that provide the highest sensitivity to 
the surrounding media we performed bulk refractive index sensitivity (BRIS) experiments. In 
500 600 700 800 900
0.0
0.5
1.0
 100
 150
 200
 250
 300
500 600 700 800 900
0.0
0.2
0.4
0.6
 
 
500 600 700 800 900
0.0
0.2
0.4
0.6
 
 
b
a
500 600 700 800 900
0.0
0.5
1.0
 200
 180
 160
 140
 120
 100
 80
r = 140nm 
c
d
E
k
Ex
ti
n
ct
io
n
Wavelength (nm)
r (nm)
s (nm)
Measurements Simulations
s
s
s = 200 nm
r
these experiments, we fabricated sensor arrays with 4 different radii (r=120, 140, 160 and 
180 nm) and with disk separations varying from 100 nm to 450 nm with 50 nm increments. 
Once integrated to the microfluidics, the fabricated sensor arrays are exposed to increasing 
concentrations of glucose solutions in ultra-pure water (Fig. 3a).   
For illustration, Fig. 3b shows the resulting redshift in the extinction spectra for r=140 nm 
and s=300 nm. Our automated parallel acquisition enables us to track in real time the 
spectrum of each of the different arrays on the chip and extract the corresponding shifts in the 
main peak centroid. For asymmetric extinction peaks like the one considered here, peak 
centroid tracking was found to be more sensitive than standard peak tracking (See 
Supplementary Fig. 2).
33
 The inset of Fig. 3c displays the real time measurement of the 
centroid shifts for the same array where different glucose concentrations are flowed in the 
channels sequentially with a step of washing with water in between. We observe 
instantaneous shifts as the refractive index of the surrounding media changes. The redshifted 
signal returns back to the baseline value for the washing steps with water ensuring that there 
is no irreversible modification of the sensors and the shifts are indeed due to bulk refractive 
index changes.  
Fig. 3c shows the evolution of the solution of the peak centroid with the refractive index for 
the same nanodisk array. From the slope of the linear fit we extract the bulk refractive index 
sensitivity (BRIS) of the sensor. The BRIS values for sensors with different disk separation 
and radius are gathered in Fig. 3d (See also supplementary Fig. 3). The arrays with 
separations larger than 300 nm were not considered as they either exhibit very low extinction, 
due to a low particle density, or resonances that were out of the spectral range of our set-up. 
Within the considered parameter range, we found that the BRIS values increased with 
increasing nanodisk separations. The highest BRIS value reached in our parameter range was 
227 nm/RIU which corresponds to the BRIS of the array with r=140 nm and s=300 nm (Fig. 
3b-d). Despite the simplicity of our structure, this BRIS value is only slightly lower than the 
previously reported BRIS values of more complex silicon nanostructure arrangements
22,23
.  
 
 
Figure 3: Bulk refractive index sensitivity (BRIS). (a) Schematics of the BRIS experiment in 
which the 8 microfluidic channels are used to flow different water/glucose  mixtures on Si 
nanodisk arrays with different s and r. (b) Evolution of the extinction spectra of a nanodisk 
array (r=140 nm, s=300 nm) exposed to 6 different glucose-water mixtures. (c) The centroid 
positions extracted from the extinction spectra in b as a function of the refractive index of the 
glucose solutions. The real time centroid shifts during the sequential flow of varying glucose 
concentrations separated by rinsing step. (d) Summary of the BRIS values obtained for 
different arrays with different radii and disk separations. The error bars are smaller than the 
data points in the plot. 
 
%
 g
lu
co
se s
1.330 1.335 1.340 1.345 1.350
844
845
846
847
848
 
 
C
e
n
tr
o
id
 w
a
v
e
le
n
g
th
 (
n
m
)
Refractive index
650 700 750 800 850 900 950
0.0
0.1
0.2
0.3
 
 
E
x
ti
n
c
ti
o
n
Wavelength (nm)
 0 
 0.75 
 1.5 
 3 
 6 
 12 
830 840 850 860
0.20
0.25
 
 
% glucose
227.0 ± 3.6 
nm/RIU
100 150 200 250 300
0
50
100
150
200
250
 
 
 r = 120 nm
 r = 140 nm
 r = 160 nm
 r = 180 nm
B
R
IS
 (
n
m
/R
IU
)
Disk separation (nm)
a
r (nm)
b
c d
0 2 4 6 8
0
2
4
 
 
C
e
n
tr
o
id
 s
h
if
t 
(n
m
)
Time (min)
r = 140 nm
s = 300 nm
r = 140 nm
s = 300 nm
For the target analyte sensing proof of concept experiments we selected the two sensors 
exhibiting the highest BRIS values (with radii of 140 and 160 nm and disk separations of 300 
and 250 nm, respectively). The experiment consists of flowing different concentrations of the 
target molecule in each of the individual channels in order to obtain an 8-point calibration 
curve. We here focused on the detection of Prostate Specific Antigen (PSA). PSA is a 34 kDa 
protein whose high concentration in blood (greater than 4-10 ng/ml) can be associated to 
prostate cancer or other prostate disorders.
34,35
 
 
Figure 4: PSA detection (a) Real time resonance shifts of the silicon nanodisk arrays 
(r=140nm, s=300nm) due to the detection of different concentration of PSA. The inset shows 
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the calculated near field distribution for one nanodisk from an infinite array. The white 
dashed line indicates the substrate-nanodisk interface. (b) Calibration curves for PSA in PBS 
buffer with 1% BSA obtained using two different sensor arrays on the same chip (inset is a 
diagram showing the sensor organization in the channels). The shaded areas on the 
calibration curves represent the dynamic ranges of the curves (purple: r=140 nm, s=300 nm 
array, orange: r=160 nm, s=250 nm array). The error bars indicate the standard deviation of 
the 2 parallel measurements on the same chip. (c) PSA calibration curve obtained in 50% 
diluted human serum for sensor with r=140 nm and s=300 nm. The shaded area defines the 
dynamic range and the error bars are the standard deviations of the 4 different measurements 
on the same chip. 
 
For the detection of PSA, the capture antibody is first immobilized on the sensor surface by 
passive adsorption by flowing the antibody solution in phosphate buffer through all 8 
channels.  The binding kinetics of the antibody to the sensor surface is monitored by tracking 
the peak centroid shifts of the silicon nanodisks. Once the signal saturation is observed, the 
sensors are washed with PBS buffer. Then, different concentrations of PSA dissolved in the 
assay buffer (PBS with 1 % BSA) are flowed in each individual channels. After another 
washing step with PBS, the detection antibody for PSA is introduced on the sensor surface 
for the detection step.  
Fig. 4a shows the real time recorded shifts of the sensors with radius of 140 nm and 
separation of 300 nm in the detection step. The channels are washed with PBS to remove 
unbound detection antibodies and reduce the bulk refractive index effect. This washing step is 
also seen in Fig. 4a, as a drop of signal after the detection antibody binding curves have 
reached the plateau. The final shifts after the washing step are extracted to obtain the 
calibration curves for PSA (Fig. 4b). The standard curves were fitted using a four-parameter 
logistic equation. The analytical parameters of the sandwich assay are shown in 
Supplementary Table 1.  
The dynamic ranges of the sensors are shown by the shaded areas on the calibration curves 
which cover the clinically relevant range for both of the sensors. The limit of detection (LOD, 
estimated as the conventional IC10 value of the four-parameter logistic curve fit) for both 
sensors are beyond the cut-off concentration for patients. The LOD for r=140 nm and r=160 
nm sensors are around 0.69 ng/ml and 0.74 ng/ml, respectively. The sensitivity of a sensor is 
conventionally defined as the IC50 value of the calibration curve which is found to be 2.45 
ng/ml and 3.24 ng/ml, respectively. We find that the sensors with higher BRIS (r=140 nm, 
s=300 nm) led to calibration curves with slightly better sensitivity and lower LOD values 
with a higher slope of the linear range of the sensors (Supplementary Table 1). The error bars 
are representing the signal variations between the replicas on the same chip and the relative 
standard deviation for intrachip reproducibility is found to be varying between 0.5% and 
5.1% for the working range of the sensors. 
Finally, to demonstrate the clinical relevance of our sensing platform, we performed the 
PSA calibration curve measurements in human serum (Fig. 4c). Serum was diluted in at 50% 
in PBS in order to reduce the matrix effects. The LOD (IC10) is 1.6 ng/ml which is below the 
cut-off value of the PSA concentration in patients and the dynamic range is between 2.5 
ng/ml and 16.0 ng/ml which covers the clinically relevant range for cancer screening. Further 
details about the analysis of the calibration curve can be found in Supplementary Table 1. 
This result suggests that the sensor performance is within the clinically relevant range and the 
measurements are feasible even in a complex matrix such as human serum. Very low shifts of 
the control channel (0.005 ± 0.035 nm) indicates negligible unspecific signal.  
In order to compare the sensing performance of our silicon nanoresonators with their 
plasmonic counterparts
11–13
, we repeated the PSA calibration curve experiment with the 
optimized gold nanorod array studied in our previous work
29
. The only significant difference 
comes from the use of EDC/NHS based surface chemistry prior to antibody immobilization 
on gold. Otherwise, both measurements were performed under the same conditions, such as 
antibody concentrations, buffers and similar flow times.  
The normalized PSA calibration curves for the gold nanorods (100 nm x 200 nm) and the 
silicon nanodisks (r=140 nm, s=300 nm) are compared in Fig. 5. The analytical parameters of 
the sandwich assay on both sensors can be found in Supplementary Table 1. The LOD (IC10) 
of the gold sensors is found to be around 0.87 ng/ml which is slightly higher than the LOD of 
the silicon based sensors. Conversely, the dynamic range of the LSPR-based sensors is 
broader for higher concentrations, giving a lower slope, which leads to higher limit of 
quantification. Besides, the assay time was much shorter for silicon based sensors since the 
LSPR sensing protocol requires self-assembled monolayer preparation and activation as well 
as blocking steps using ethanolamine (Supplementary Fig. 4).  
 
Figure 5: Comparison of the Si and Au platforms. PSA calibration curves for gold nanorod 
arrays (gold) and silicon nanodisk arrays (purple). Both curves were normalized for clearer 
comparison. The error bars represent the standard deviation of 2 parallel measurements on the 
same chip. The shaded areas are the respective dynamic ranges. The inset shows the 
experimental extinction spectra of gold nanorod arrays and silicon nanodisk arrays. 
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We have studied the use of silicon nanoresonators integrated in a state-of-the-art 
microfluidic architecture for biosensing. We demonstrated that the resulting platform is 
compatible with detection of small biomolecules in complex matrices for clinical 
applications. The reported sensing performance enables us to detect clinically relevant 
concentrations of PSA.  
We have also compared our platform with a well-developed LSPR-based sensing protocol 
and shown that the sensitivity, LOD and the dynamic ranges are comparable. Besides the 
similar sensing performance, one of the advantages of the silicon based sensors is the 
significantly longer decay length of the surface field over LSPR modes in metal 
nanoantennas (Supplementary Fig. 1), which can be beneficial for multilayer assays 
involving detection of molecules relatively far from the surface. This suggests that in 
comparison with LSPR sensors, different assay types with multiple layers of antibodies can 
be efficiently monitored using the silicon nanoresonators which in practice enables more 
practical and faster detection of the target analyte. 
The extinction of the Si nanoresonators considered here is much lower compared to the 
extinction of the gold nanoantennas (inset Fig. 5). This suggests that for Si resonators there is 
still room for improvement by tailoring the shape, size, periodicity and height of 
nanoresonator arrays in order to obtain sharper, stronger and potentially more sensitive 
resonances. We thus foresee further engineering of the Si nanoresonators including 
arrangement in dimers and oligomers, that could improve the sensing performance. However, 
more complex nanostructuring of the silicon might also affect the local sensitivity to 
molecular adsorption at the surface of the nanoresonators. While the location of the adsorbed 
antibodies is not controlled in the present study (see Supplementary Fig. 5 for a simulation of 
the comparison of various cases), this parameter can become important when studying more 
complicated designs.  
Finally, the quality of the sandwich assay, hence the LOD and sensitivity, can further be 
improved by additional optimizations of the capture and detection antibody concentrations. 
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